Strides Pharma Sci Ltd

STAR NSE Healthcare Pharmaceuticals
Microcap 250
₹1,183.40
-2.76%
Delayed · cached 15 min

Fair value analysis

STAR
Strides Pharma Sci Ltd
Healthcare›Pharmaceuticals
₹1,217.00
Close used for this calculation
₹1,416.66Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
63/100
Profitability19/25
Returns15/25
Balance Sheet14/25
Efficiency15/25
Growth14/25
Good
Quality radar
63Prof.19/25Ret.15/25Eff.15/25B.Sht14/25Growth14/25

Consensus fair value

₹1,416.66
Below FV
▲ +16.4% against the close used
Model range ₹644.43 – ₹2,168.36
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹644.43Fair value₹1,416.66Bull₹2,168.36
FairClose
52-week traded range
52W low ₹793.5552W high ₹1,217.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Strides Pharma Sci Ltd closed at ₹1,217.00, 14.1% below the consensus fair value of ₹1,416.66 drawn from 9 valuation models.

Financial DNA score 63/100 — Good. P/E of 18.8x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₹644.43
-47.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹700.20
-42.5%
√(22.5 × EPS × BVPS)
EPS=60.34, BVPS=361.13 · outside Graham range (P/E 18.8, P/B 3.4) — asset-light, treat as a rough floor
Graham Formula
₹2,168.36
+78.2%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=15.1%, FD=7%
P/E Fair Value
₹2,154.14
+77.0%
EPS × 35.7x (sector P/E)
EPS=60.34, Sector P/E=35.7x
Peter Lynch (PEG)
₹911.13
-25.1%
EPS × Growth% (PEG = 1 is fair)
EPS=60.34, g=15.1%
EV/EBITDA
₹2,010.58
+65.2%
(EBITDA × 17.6x − Net Debt) ÷ Shares
EBITDA=11.27B
Book Value (P/B)
₹1,263.95
+3.9%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=361.13, ROE=20%, g=6%, r=10%
Reverse DCF
₹1,217.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 7.3% | Historical: 15.1%
Margin of Safety
₹1,062.59
-12.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=1416.78, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.